TMS, Ketamine, Psychedelics, and More: Emerging Treatments and their Applications in Integrative Pediatric Psychiatry
- Speaker:
- Erin Amato, MD
- Duration:
- 1 Hour 02 Minutes
- Format:
- Audio and Video
- Copyright:
-
Nov 04, 2023
- Product Code:
- POS078694
- Media Type:
- Digital Seminar
Description
Depression is the leading cause of disability worldwide and nearly 1/3 of patients do not find relief with antidepressant medications. Clinicians and patients desperately need more effective, safe treatment options. TMS, ketamine, and psychedelics are breakthrough interventions that are bringing hope for people suffering from treatment-resistant mental health conditions. This session will discuss the evolution of these treatments and give you tools to use them in an integrative approach to helping your patients.
Credit
Handouts/Brochure
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Ketamine, TMS, and Psychedelics and How These Fit in the Landscape of Integrative Treatments for Mental Health Disorders in Adolescents (8.2 MB) | 41 Pages | Available after Purchase |
Speaker
Erin Amato, MD Related seminars and products
Erin Amato, MD, is a double board-certified child, adolescent, and adult psychiatrist with Montana Psychiatry & Brain Center in Billings, Montana. She is also a fellow of anti-aging, metabolic and functional medicine through the Metabolic Medical Institute of A4M, and a fellow of the Integrative Psychiatry Institute. She is passionate about finding cutting-edge, innovative ways to prevent and treat mental health disorders that have not responded to traditional interventions. She is on the board of the American Society of Ketamine Physicians, Psychotherapists, and Practitioners and has overseen the administration of thousands of IV ketamine and esketamine treatments since 2014. She received training in Transcranial Magnetic Stimulation (TMS) and other non-invasive brain modulation techniques at the Brain Stimulation Laboratory of Medical University of South Carolina and has been performing TMS for the treatment of depression since 2015. She completed training with the Psychedelic Research and Training Institute for ketamine and psychedelic therapy in 2020. She is an integrative psychiatrist who looks to blend traditional treatment tools, like medication and talk therapy, with functional medicine testing, nutritional supplementation, and lifestyle education to design personalized treatment approaches that target the root causes of illness.
Speaker Disclosures:
Financial: Dr. Erin Amato has employment relationships with Montana Psychiatry PLLC, the Mood Restoration Institute, and the Yellowstone Boys and Girls Ranch. She receives a speaking honorarium from Janssen Pharmaceuticals and a consulting fee from Turnwell Mental Health Network. Dr. Amato receives a speaking honorarium from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Dr. Erin Amato is a member of the American Academy of Anti-Aging Medicine, the American Society of Ketamine Physicians, the Clinical TMS Society, the Montana Medical Association, and the American Academy of Child and Adolescent Psychiatry.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Outline the evolution of TMS in the treatment of depression and other treatment-resistant psychiatric conditions.
- Discuss FDA approved indications for TMS, patient selection, and safety considerations.
- Explain the indications, patient selection, and risks of ketamine and esketamine for depression and other psychiatric conditions.
- Explore principles of ketamine assisted psychotherapy and how these apply to various practice models.
- Outline emerging treatments in psychedelic psychiatry including legal and safety concerns.
Outline
Emerging psychiatric treatments for children and adolescents
- Considering integrative approaches in mental health care
Use of CBD in Children and Adolescents
- Prevalence of anxiety and insomnia in this age group
- Studies on the use of CBD for anxiety and insomnia in children and adolescents
- Transcranial Magnetic Stimulation (TMS) for Adolescent Major Depressive Disorder
- Major Depressive Disorder in adolescents
- TMS as a treatment
- Effectiveness and safety of TMS in treating adolescent depression
Ketamine and Esketamine for Mental Health Disorders in Adolescents
- Recent studies on the use of ketamine and esketamine in adolescents
Psychedelics and Emerging Applications
- Cultural and societal perceptions of psychedelics
- Applications of psychedelics in treating mental health conditions in adolescents
- Unique considerations and risks in pediatric populations
- Ethical considerations and informed consent
Target Audience
- Addiction Counselors
- Case Managers
- Counselors
- Marriage and Family Therapists
- Nurses
- Psychologists
- Psychotherapists
- Social Workers
- Therapists
- Psychiatrists
- Other Mental Health Professionals
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...



